M. A. Pfaller, M. Bassetti, L. R. Duncan, and M. Castanheira, Ceftolozane/tazobactam 187 activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing 188 urinary tract and intraabdominal infections in Europe: report from an antimicrobial 189 surveillance programme (2012-15), J Antimicrob Chemother, vol.72, issue.5, pp.1386-1395, 2017.

,

R. Bonnet, J. L. Sampaio, C. Chanal, D. Sirot, D. Champs et al., , 2000.

, A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens 193 isolated in Brazil, Antimicrob Agents Chemother, vol.44, issue.11, pp.3061-3069

C. De-champs, C. Chanal, D. Sirot, R. Baraduc, J. P. Romaszko et al., , p.195

E. Carroy, M. C. Gbadamassi, S. Laluque, O. Oules, M. C. Poupart et al., , 2004.

, Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of 197 the Auvergne, France: a 2 year prospective study, J Antimicrob Chemother, vol.54, issue.3, pp.634-643

F. J. Pérez-pérez, N. Hanson, F. Robin, R. Beyrouthy, S. Bonacorsi et al., Detection of plasmid-mediated AmpC beta-lactamase 199 genes in clinical isolates by using multiplex PCR, J Clin Microbiol, vol.40, issue.6, pp.2153-62, 2002.

H. , D. N. Doucet-populaire, F. Dubois, V. Fortineau, N. Grillon et al., Leyssene, vol.202

D. , P. I. Podglajen, I. Recule, C. , R. A. Colomb-cotinat et al., , p.204, 2017.

, France as Assessed by a Multicenter Study, Antimicrob Agents Chemother, vol.61, issue.3, pp.205-01911

D. Shortridge, M. A. Pfaller, M. Castanheira, and R. K. Flamm, Antimicrobial Activity, p.207, 2017.

. Ceftolozane-tazobactam, Tested Against Enterobacteriaceae and Pseudomonas 208 aeruginosa with Various Resistance Patterns

, Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam 210

, Susceptibility. Microb Drug Resist, vol.17

M. J. Melchers, A. C. Van-mil, and J. W. Mouton, Vitro Activity of Ceftolozane Alone and in 212 Combination with Tazobactam against Extended-Spectrum-?-Lactamase-Harboring, p.213, 2015.

. Enterobacteriaceae, Antimicrob Agents Chemother, vol.59, issue.8, pp.4521-4526

,

D. M. Livermore, S. Mushtaq, D. Meunier, K. L. Hopkins, R. Hill et al., , p.216

P. Staves and N. Woodford, BSAC Resistance Surveillance Standing Committee. Activity 217 of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, p.218, 2017.

, Pseudomonas aeruginosa and non-fermenters from the British Isles, J Antimicrob 219 Chemother, vol.72, issue.8, pp.2278-2289